Biogen Exercises Samsung Bioepis Call Option - Summary & Implications
Samsung Biologics Co., Ltd (207940 KS) said in a regulatory filing that Biogen Inc (BIIB US) exercised Bioepis call option. Link of this...
261 Views
The Resurgence of Feature Phones Could Upstage Xiaomi's Plans for India
What can be said about Xiaomi Corp (1810 HK) that hasn’t already been said? Xiaomi’s product and geographic segments have been well discussed on...
189 Views
Xiaomi IPO Review - Amazing Products, Honest Pricing. Just Not the IPO.
Xiaomi Corp (1810 HK) is looking to raise up to US$6bn in its upcoming IPO. Proceeds will be used for research and development of core in-house...
791 Views
3D NAND Oversupply Expected to Correct Itself By Year End?
3D NAND is the latest development in NAND flash after 2D NAND faced roadblocks from downsizing issues and current leakages. The transition to the...
115 Views
Xiaomi IPO Valuation: A Rough Guide to Cutting the Valuation
Xiaomi Corp (1810 HK) has finally kicked off bookbuilding for its Hong Kong IPO. At the mid-point of the IPO price range of HK$17-$22 per share,...
817 Views